Yoshizumi M, Kitagawa T, Masuda Y, Horike K, Ogawa Y, Suzuki Y, Tamaki T, Katoh I
Department of Cardiovascular Surgery, School of Medicine, University of Tokushima, Japan.
Scand Cardiovasc J. 1998;32(3):167-72. doi: 10.1080/14017439850140148.
The effect of amiloride, a potent inhibitor of Na+/H+ exchange, on ischaemic reperfused rat hearts was studied in order to investigate whether Na+/H+ exchange or Na+/Ca2+ exchange is involved in ischaemia-reperfusion injury, When hearts were pre-ischaemically loaded with 100 microM amiloride, recovery of left ventricular developed pressure was significantly better than in control hearts, whereas recovery of heart rate at 30-min reperfusion was unaffected. Amiloride pretreatment also decreased creatine phosphokinase activity in the coronary effluent and completely abolished occurrence of ventricular arrhythmias during reperfusion. It also inhibited intracellular Na+ accumulation early in reperfusion (within 5 min), whereas in the late stage (from 5 to 30 min), Ca2+ overload was inhibited. The findings suggest that Na+/H+ exchange participates mainly in the early stage of reperfusion injury and the Na+/Ca2+ exchange system, secondary to Na+/H+ exchange, in the late stage. The reduction in post-ischaemic cardiac dysfunction induced by amiloride pretreatment may be attributable to inhibition of the resultant Ca2+ accumulation during reperfusion.
为了研究钠氢交换或钠钙交换是否参与缺血再灌注损伤,研究了强效钠氢交换抑制剂氨氯吡咪对缺血再灌注大鼠心脏的影响。当心脏在缺血前用100微摩尔氨氯吡咪负荷时,左心室舒张末压的恢复明显优于对照心脏,而在再灌注30分钟时心率的恢复未受影响。氨氯吡咪预处理还降低了冠状动脉流出液中的肌酸磷酸激酶活性,并完全消除了再灌注期间室性心律失常的发生。它还在再灌注早期(5分钟内)抑制细胞内钠的积累,而在后期(5至30分钟),抑制钙超载。这些发现表明,钠氢交换主要参与再灌注损伤的早期阶段,而钠钙交换系统继发于钠氢交换,参与后期阶段。氨氯吡咪预处理引起的缺血后心脏功能障碍的减轻可能归因于对再灌注期间由此产生的钙积累的抑制。